Joel Habener: Difference between revisions
Content deleted Content added
mNo edit summary |
bold title |
||
| Line 1: | Line 1: | ||
Joel Habener is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and [[Jens Juul Holst]].<ref>https://warrenalpert.org/prize-recipients</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html</ref> |
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and [[Jens Juul Holst]].<ref>https://warrenalpert.org/prize-recipients</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html</ref> |
||
==References== |
==References== |
||
Revision as of 16:50, 25 June 2020
Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2]
References
 | This article has not been added to any content categories. Please help out by adding categories to it so that it can be listed with similar articles. (June 2020) |